[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CY1109153T1 - Ενωσεις υποκατεστημενου κυκλοπεντανιου και κυκλοπεντενιου χρησιμες ως αναστολεις νευραμινιδασης - Google Patents

Ενωσεις υποκατεστημενου κυκλοπεντανιου και κυκλοπεντενιου χρησιμες ως αναστολεις νευραμινιδασης

Info

Publication number
CY1109153T1
CY1109153T1 CY20091100635T CY091100635T CY1109153T1 CY 1109153 T1 CY1109153 T1 CY 1109153T1 CY 20091100635 T CY20091100635 T CY 20091100635T CY 091100635 T CY091100635 T CY 091100635T CY 1109153 T1 CY1109153 T1 CY 1109153T1
Authority
CY
Cyprus
Prior art keywords
cyclopentane
compounds useful
substituted
neuraminidase inhibitors
neuraminidase
Prior art date
Application number
CY20091100635T
Other languages
English (en)
Inventor
Yarlagadda S Babu
Pooran Chand
John A Montgomery
Original Assignee
Biocryst Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocryst Pharmaceuticals, Inc. filed Critical Biocryst Pharmaceuticals, Inc.
Publication of CY1109153T1 publication Critical patent/CY1109153T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/48—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00—Compounds containing azido groups
    • C07C247/14—Compounds containing azido groups with azido groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

Ενώσεις αντιπροσωπευόμενες από τους τύπους (I, II ή III) όπου U είναι CH, Ο ή S·
CY20091100635T 1997-12-17 2009-06-16 Ενωσεις υποκατεστημενου κυκλοπεντανιου και κυκλοπεντενιου χρησιμες ως αναστολεις νευραμινιδασης CY1109153T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6995697P 1997-12-17 1997-12-17
US8525298P 1998-05-13 1998-05-13
EP98966003.0A EP1040094B9 (en) 1997-12-17 1998-12-17 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors

Publications (1)

Publication Number Publication Date
CY1109153T1 true CY1109153T1 (el) 2014-07-02

Family

ID=26750600

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20091100635T CY1109153T1 (el) 1997-12-17 2009-06-16 Ενωσεις υποκατεστημενου κυκλοπεντανιου και κυκλοπεντενιου χρησιμες ως αναστολεις νευραμινιδασης
CY2018023C CY2018023I2 (el) 1997-12-17 2018-08-30 Ενωσεις υποκατεστημενου κυκλοπεντανιου και κυκλοπεντενιου χρησιμες ως αναστολεις νευραμινιδασης

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY2018023C CY2018023I2 (el) 1997-12-17 2018-08-30 Ενωσεις υποκατεστημενου κυκλοπεντανιου και κυκλοπεντενιου χρησιμες ως αναστολεις νευραμινιδασης

Country Status (28)

Country Link
US (1) US6562861B1 (el)
EP (1) EP1040094B9 (el)
JP (3) JP4102022B2 (el)
KR (1) KR20010024743A (el)
CN (1) CN1282316A (el)
AR (1) AR016162A1 (el)
AT (1) ATE425955T1 (el)
AU (1) AU2200199A (el)
BE (1) BE2018C032I2 (el)
BR (1) BR9813480A (el)
CA (1) CA2315262C (el)
CY (2) CY1109153T1 (el)
DE (1) DE69840674D1 (el)
DK (1) DK1040094T3 (el)
ES (1) ES2324746T3 (el)
FR (1) FR18C1037I2 (el)
HU (1) HUP0100142A3 (el)
IL (1) IL136812A0 (el)
LT (1) LTC1040094I2 (el)
NL (1) NL300952I2 (el)
NO (1) NO20003084L (el)
PL (1) PL196674B1 (el)
PT (1) PT1040094E (el)
RO (1) RO121815B1 (el)
SI (1) SI1040094T1 (el)
SK (1) SK8712000A3 (el)
WO (1) WO1999033781A1 (el)
ZA (1) ZA9811595B (el)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT933993E (pt) 1996-06-14 2006-10-31 Biocryst Pharm Inc Compostos de ciclopentano substituidos, uteis como inibidores de neuraminidase
KR20010024743A (ko) * 1997-12-17 2001-03-26 몽고메리 죤 에이 뉴라미니다아제 감염저해 물질로서 유용한 치환된시클로펜탄 및 시클로펜틴 화합물
WO1999054290A1 (en) * 1998-04-23 1999-10-28 Abbott Laboratories Inhibitors of neuraminidases
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
US6518305B1 (en) * 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
WO2000028328A1 (en) 1998-11-05 2000-05-18 Biocryst Pharmaceuticals, Inc. New cyclopentane and cyclopentene compounds and use for detecting influenza virus
US6762316B1 (en) * 1999-06-28 2004-07-13 Biocryst Pharmaceuticals, Inc. Preparation of substituted cyclopentane and cyclopentene compounds and certain intermediates
EP1206443A2 (en) * 1999-06-28 2002-05-22 Biocryst Pharmaceuticals, Inc. Process for preparing (-)-(1s,4r) n-protected 4-amino-2-cyclopentene-1-carboxylate esters
BR0011902A (pt) * 1999-06-28 2002-03-19 Biocryst Pharm Inc Compostos derivados de ciclopentano substituìdo, respectivos processos de preparação e formas cristalinas
CA2377287A1 (en) * 1999-06-28 2001-01-04 Biocryst Pharmaceuticals Inc. Preparation of substituted cyclopentane and cyclopentene compounds and certain intermediates
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
US6627396B1 (en) 1999-10-28 2003-09-30 The Regents Of The University Of California Influenza sensor
WO2001062242A1 (en) * 2000-02-24 2001-08-30 Biocryst Pharmaceuticals, Inc. Prodrugs of substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
ATE414079T1 (de) * 2000-03-01 2008-11-15 Janssen Pharmaceutica Nv 2,4-disubstituierte thiazolyl derivate
AU2001252578A1 (en) * 2000-04-25 2001-11-07 Sankyo Company Limited Preventives for influenza
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments
AUPR001000A0 (en) 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
EP1334969A4 (en) * 2000-10-18 2005-08-24 Kuraray Co PREPARATION OF 4-N SUBSTITUTED AMINO-2-AZA-1-OXYBICYCLO 3.3.0] OCT-2-ENE-6-CARBOXYLIC ACID ESTERS AND PREPARATION OF THEIR INTERMEDIATE PRODUCTS
WO2002092555A1 (fr) * 2001-05-11 2002-11-21 Sankyo Company, Limited Derives d'acides sialiques
WO2006066074A2 (en) * 2004-12-16 2006-06-22 The Regents Of The University Of California Lung-targeted drugs
WO2007087056A2 (en) * 2006-01-13 2007-08-02 Scolr Pharma, Inc. Peramivir derivative for oral administration
EA025483B1 (ru) * 2006-02-13 2016-12-30 Байокрист Фармасьютикалз, Инк. Внутривенный способ лечения сезонного гриппа
CN101420948A (zh) 2006-02-13 2009-04-29 拜奥克里斯特制药公司 静脉内抗病毒治疗
CA2649090A1 (en) * 2006-04-12 2007-10-18 Biocryst Pharmaceuticals, Inc. Intramuscular antiviral treatments
US20070244193A1 (en) * 2006-04-12 2007-10-18 Babu Yarlagadda S Intramuscular antiviral treatments
CN100432047C (zh) * 2006-07-03 2008-11-12 华南农业大学 一种抗流感及禽流感病毒药物帕拉米韦的合成方法
JP5345073B2 (ja) 2007-01-23 2013-11-20 テラピコン エス．アール．エル． 抗ウイルス化合物
US20080194801A1 (en) * 2007-02-14 2008-08-14 Swanson Basil I Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses
US8933225B2 (en) * 2007-08-02 2015-01-13 Millennium Pharmaceuticals, Inc. Process for the synthesis of E1 activating enzyme inhibitors
CN101367750B (zh) * 2007-08-14 2012-05-23 中国人民解放军军事医学科学院毒物药物研究所 (1s,2s,3s,4r)-3-[(1s)-1-乙酰氨-2-乙基-丁基]-4-胍基-2-羟基-环戊基-1-羧酸水合物及其医药用途
US8609139B2 (en) * 2007-11-05 2013-12-17 Ala Wai Pharma, Inc. Formulations for enhanced bioavailability of orally administered polar agents
AU2014200052B2 (en) * 2007-11-05 2016-01-07 Ala Wai Pharma, Inc. Formulations for enhanced bioavailability of orally administered polar agents
CN101538228B (zh) * 2008-03-21 2012-05-30 北京普世康医药技术有限公司 抗流感和禽流感病毒药物化合物帕拉米韦的合成方法
CN101486664B (zh) * 2008-12-31 2013-09-04 北京大学深圳研究生院 用作流感病毒神经氨酸酶抑制剂的多取代五元环小分子化合物
US8877945B2 (en) 2009-05-15 2014-11-04 Redx Pharma Limited Redox drug derivatives
IT1396620B1 (it) 2009-11-25 2012-12-14 Therapicon Srl Analoghi chimerici
EP2576553A4 (en) 2010-05-27 2013-11-20 Reddys Lab Ltd Dr EXTREMELY SELECTIVE ASYMMETRIC HYDROFORMYLATION OF (+) OR (-) - LACTAM (1S, 4R) - OR (1R, 4S) -2-AZABICYCLO [2.2.1] HEPT-5-EN-3-ONE
CN102584637B (zh) * 2011-01-17 2014-07-09 天津药物研究院 帕拉米韦水合物晶体、制备方法、药用组合物及其用途
CN102603577A (zh) * 2011-01-19 2012-07-25 董慧珍 一种抗流感和禽流感药物的衍生物及其用途
CN102757365B (zh) * 2011-04-29 2013-10-30 上海泓博智源医药技术有限公司 一种制备帕拉米韦关键中间体的方法
CN103827082B (zh) * 2011-04-29 2016-01-20 上海泓博智源医药技术有限公司 一种制备帕拉米韦及其中间体的新工艺
CN102964267B (zh) * 2011-09-01 2015-06-10 中山大学 一种具有流感病毒神经氨酸酶抑制活性的环己烯化合物及其制备方法以及其应用
CN102863359B (zh) * 2012-05-16 2014-05-07 常州制药厂有限公司 一种抗流感药物的合成方法
CN102702033A (zh) * 2012-06-11 2012-10-03 天津泰普药品科技发展有限公司 无定型帕拉米韦及其制备方法与药物组合物
EP2912047B1 (en) 2012-10-29 2016-08-24 Cipla Limited Antiviral phosphonate analogues and process for preparation thereof
AU2014228321C1 (en) 2013-03-15 2019-07-11 The Regents Of The University Of California Acyclic nucleoside phosphonate diesters
CA2911424C (en) 2013-05-14 2021-11-30 Biocryst Pharmaceuticals, Inc. Anti-influenza imino-ribose pyrrolopyrimidine derivatives
CN105294589B (zh) * 2014-06-18 2017-06-30 朱靖华 一种抗病毒药物及其制备方法
DK3194411T3 (da) 2014-09-15 2022-05-30 Univ California Nukleotidanaloger
CN104387288B (zh) * 2014-11-25 2016-04-20 广东东阳光药业有限公司 作为神经氨酸酶抑制剂的化合物及其在药物中的应用
CN104496839B (zh) * 2014-12-03 2016-04-20 广东东阳光药业有限公司 取代环丁烷类神经氨酸酶抑制剂及其使用方法和用途
CN104496838B (zh) * 2014-12-03 2016-04-20 广东东阳光药业有限公司 取代环丁烷类神经氨酸酶抑制剂及其使用方法和用途
CN104496857B (zh) * 2014-12-10 2016-10-12 广东东阳光药业有限公司 作为神经氨酸酶抑制剂的化合物及其在药物中的应用
CN105198827A (zh) * 2015-04-13 2015-12-30 广州南新制药有限公司 一种帕拉米韦中间体的合成方法
NZ739621A (en) * 2015-08-10 2024-08-30 Alzheon Inc Compositions and methods for treating and preventing neurodegenerative disorders
CN106220515A (zh) * 2016-08-12 2016-12-14 郸城巨鑫生物科技有限公司 一种(1r,4s)‑1‑氨基‑4‑羟甲基‑2‑环戊烯盐酸盐的合成方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT979736B (it) 1972-03-07 1974-09-30 Ethyl Corp Detersivo contenente un sequestran te e relativo metodo di impiego
US4089897A (en) * 1976-05-10 1978-05-16 Minnesota Mining And Manufacturing Company Geminal prostaglandin analogs
US4426391A (en) 1982-09-15 1984-01-17 Merck & Co., Inc. [(Alkoxycarbonyl)oxy]alkyl esters of methyldopa
JPS59163365A (ja) 1983-03-08 1984-09-14 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物
DE3475065D1 (en) 1983-06-23 1988-12-15 Merck & Co Inc (acyloxyalkoxy) carbonyl derivatives as bioreversible prodrug moieties for primary and secondary amine functions in drugs, their preparation and pharmaceutical compositions containing said derivatives
ZA878096B (en) * 1986-11-03 1988-04-26 Merrell Dow Pharmaceuticals Inc. Esters of hexahydro-8-hydroxy-2,6-methano-2h-quinolizin-3(4h)-one and related compounds
US4873019A (en) 1986-12-20 1989-10-10 Merck Patent Gesellschaft Mit Beschrankter Haftung Cyclopentane derivatives
ES2075429T3 (es) * 1990-02-02 1995-10-01 Schering Corp Derivados de 4,5-cicloalcano-3-benzazepin-7-ol y sus usos.
AU1566192A (en) 1991-03-12 1992-10-21 Mect Corporation Synthesis of sialic acid and synthetic intermediate therefor
JP2951765B2 (ja) 1991-09-10 1999-09-20 三共株式会社 エナミノエステル類およびその製法
AU673824B2 (en) * 1992-05-29 1996-11-28 Bayer Aktiengesellschaft Cyclopentane- and -pentene-beta-amino acids
JPH07145120A (ja) * 1993-11-25 1995-06-06 Kuraray Co Ltd ｃｉｓ−４−アミノ−２−シクロペンテン−１−カルボン酸の製造法
WO1995023157A1 (en) * 1994-02-25 1995-08-31 E.I. Du Pont De Nemours And Company 4-n-substituted sialic acids and their sialosides
US5453533A (en) * 1994-04-14 1995-09-26 The University Of Alabama At Birmingham Inhibitors of influenza virus neuraminidase and methods of making and using the same
US5789434A (en) * 1994-11-15 1998-08-04 Bayer Corporation Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
BR9607098A (pt) * 1995-02-27 1997-11-04 Gilead Sciences Inc Novos inibidores seletivos de neuraminidas virais ou bacterianas
CA2176414A1 (en) 1995-05-18 1996-11-19 S. David Kimball Acyl guanidine and amidine prodrugs
AU709127B2 (en) * 1995-05-19 1999-08-19 Biota Scientific Management Pty Ltd 6-carboxamido dihydropyran derivatives
GB9516276D0 (en) * 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
PT933993E (pt) * 1996-06-14 2006-10-31 Biocryst Pharm Inc Compostos de ciclopentano substituidos, uteis como inibidores de neuraminidase
JP2001512439A (ja) 1997-02-06 2001-08-21 メルク エンド カンパニー インコーポレーテッド 線維素原受容体拮抗薬プロドラッグ
ID25516A (id) * 1997-09-17 2000-10-05 Gilead Sciences Inc Senyawa-senyawa yang mengandung cincin-cincin beranggotakan enam, proses pembuatannya, dan penggunaannya sebagai obat
KR20010024743A (ko) * 1997-12-17 2001-03-26 몽고메리 죤 에이 뉴라미니다아제 감염저해 물질로서 유용한 치환된시클로펜탄 및 시클로펜틴 화합물
SK15092000A3 (sk) 1998-04-23 2001-05-10 Abbott Laboratories Pyrolidíny ako inhibítory neuraminidáz
WO1999054290A1 (en) 1998-04-23 1999-10-28 Abbott Laboratories Inhibitors of neuraminidases

Also Published As

Publication number Publication date
RO121815B1 (ro) 2008-05-30
JP4102022B2 (ja) 2008-06-18
JP2011256196A (ja) 2011-12-22
PL196674B1 (pl) 2008-01-31
EP1040094B9 (en) 2015-09-09
SI1040094T1 (sl) 2009-10-31
CN1282316A (zh) 2001-01-31
CY2018023I1 (el) 2018-12-12
BE2018C032I2 (el) 2018-10-15
US6562861B1 (en) 2003-05-13
CA2315262C (en) 2009-11-10
ES2324746T3 (es) 2009-08-13
IL136812A0 (en) 2001-06-14
AR016162A1 (es) 2001-06-20
BR9813480A (pt) 2000-10-10
EP1040094A1 (en) 2000-10-04
KR20010024743A (ko) 2001-03-26
JP2008163035A (ja) 2008-07-17
LTC1040094I2 (lt) 2018-11-26
JP2001527058A (ja) 2001-12-25
NL300952I2 (nl) 2018-09-27
JP5709688B2 (ja) 2015-04-30
JP5118502B2 (ja) 2013-01-16
PT1040094E (pt) 2009-06-03
HUP0100142A3 (en) 2002-01-28
SK8712000A3 (en) 2000-11-07
CA2315262A1 (en) 1999-07-08
PL341431A1 (en) 2001-04-09
ZA9811595B (en) 2000-06-19
LTPA2018513I1 (lt) 2018-10-10
EP1040094A4 (en) 2004-12-08
ATE425955T1 (de) 2009-04-15
WO1999033781A1 (en) 1999-07-08
FR18C1037I1 (fr) 2018-12-10
AU2200199A (en) 1999-07-19
NO20003084L (no) 2000-08-14
HUP0100142A2 (hu) 2001-05-28
DK1040094T3 (da) 2009-06-02
CY2018023I2 (el) 2018-12-12
DE69840674D1 (de) 2009-04-30
NO20003084D0 (no) 2000-06-15
FR18C1037I2 (fr) 2019-06-21
EP1040094B1 (en) 2009-03-18

Similar Documents

Publication Publication Date Title
CY1109153T1 (el) Ενωσεις υποκατεστημενου κυκλοπεντανιου και κυκλοπεντενιου χρησιμες ως αναστολεις νευραμινιδασης
ES2182234T3 (es) Inhibidores de metaloproteasa.
PT1193270E (pt) Pirrolobenzodiazepinas
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
CY1108456T1 (el) Ενωσεις βενζιμιδαζολονης
BR0114646A (pt) anticorpos anti-lt-beta-r humanizados
EA199700061A1 (ru) Способ получения силденафила
CY1105836T1 (el) 12, 13-τροποποιημενα παραγωγα εποθιλονης
BR9804214A (pt) Compostos.
DE69803907D1 (de) Fungizide 2-Methoxybenzophenone
DK0944643T3 (da) Oxyiminopregnancarbolactoner.
SE9702773D0 (sv) Novel compounds
BR9711586A (pt) Compostos e uso dos mesmo
ATE332903T1 (de) Kondensierte pyridoindolderivate
ATE288900T1 (de) Substituierte benzoylcyclohexandione
EP0330041A3 (de) Substituierte 1,2,4-Triazindione, Verfahren zu ihrer Herstellung und ihre Verwendung
DE60112960D1 (de) Kondensierte pyridoindolderivate
EA200100854A1 (ru) Кальций-литические соединения
SE9903290D0 (sv) Novel compounds
FI962481A (fi) 4-bentsoyyli-isokatsolit ja niiden käyttö herbisideinä
EA199900235A1 (ru) Аморфные бензотиофены, способы получения и способы применения
BR0316544A (pt) Compostos calcilìticos
DE69703115D1 (de) Zwischenprodukte um 2-imidazolin-5onederivate herzustellen.
ATE213236T1 (de) Substituierte benzyloxyimino-verbindungen
DK1019347T3 (da) Fremgangsmåde til syntesen af taxaner